Chemours
443 hedge funds and large institutions have $3.02B invested in Chemours in 2024 Q1 according to their latest regulatory filings, with 60 funds opening new positions, 124 increasing their positions, 133 reducing their positions, and 81 closing their positions.
102% more call options, than puts
Call options by funds: $112M | Put options by funds: $55.2M
0.45% more ownership
Funds ownership: 77.05% → 77.51% (+0.45%)
7% less repeat investments, than reductions
Existing positions increased: 124 | Existing positions reduced: 133
6% less funds holding
Funds holding: 469 → 443 (-26)
16% less capital invested
Capital invested by funds: $3.61B → $3.02B (-$585M)
26% less first-time investments, than exits
New positions opened: 60 | Existing positions closed: 81
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$88.5M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$49.9M |
| 3 |
KCM
Khrom Capital Management
Miami Beach,
Florida
|
+$38.9M |
| 4 |
VNIM
Vaughan Nelson Investment Management
Houston,
Texas
|
+$36M |
| 5 |
JP Morgan Chase
New York
|
+$15.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
-$120M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$41.4M |
| 3 |
Morgan Stanley
New York
|
-$28.5M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$26.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$17.5M |
CC Hedge Fund Activity: Q1 2024 in Review
443 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q1 2024, worth a combined $3.02B — down 16% from $3.61B a quarter earlier.
Sellers outnumbered buyers: 81 funds closed out of CC and 60 opened new positions — a net loss of 21 holders — while 133 trimmed existing stakes and 124 added.
The largest buyer was Fidelity Investments, adding an estimated $88.5M. The largest seller was Bank of New York Mellon, cutting an estimated $120M.
- 443 institutional investors held Chemours (CC) as of Q1 2024, down from 469 in Q4 2023.
- Funds reported $3.02B of Chemours stock for Q1 2024, down 16% quarter-over-quarter.
- 60 funds opened new Chemours positions in Q1 2024 and 81 closed out, a net change of -21 holders.
- The largest Chemours buyer in Q1 2024 was Fidelity Investments, an estimated $88.5M added.
- The largest Chemours seller in Q1 2024 was Bank of New York Mellon, an estimated $120M sold.
Based on aggregated 13F filings for Q1 2024.